靶向药物递送的莲座纳米管

Nanotechnologies for the Life Sciences Pub Date : 2012-02-15 DOI:10.1002/9783527610419.NTLS0262

S. Suri, H. Fenniri, Baljit Singh

{"title":"靶向药物递送的莲座纳米管","authors":"S. Suri, H. Fenniri, Baljit Singh","doi":"10.1002/9783527610419.NTLS0262","DOIUrl":null,"url":null,"abstract":"The sections in this article are \n \n \nIntroduction \nPeptide-Based Nanotubes \nSelf-Assembling Rosette Nanotubes \nSelf-Assembly Peptides \nG∧C Motif Self-Assembly: Novel Helical Rosette Nanotubes \nNovelty \nG∧C Motif Self-Assembly Process \nBuilt-In Strategy for Manipulating the Properties of RNTs \n \n \nBiological Functions of RNTs \n \n \nStability Issues \nNanomaterials for Receptor-Mediated Targeting \nHuman Epidermal Growth Factor Receptor (EGFR) \nVasoactive Pituitary Adenylate Cyclase (VPAC)-Activating Peptide Receptors \nTransferrin Receptor (TfR) \nFolate Receptor (FR) \n \n \nEthical Issues and Future Directions \nConclusions \n \n \nKeywords: \n \nbiofriendly nanotubes; \ndrug delivery; \ncancer; \ninflammation; \nnanotechnology","PeriodicalId":312946,"journal":{"name":"Nanotechnologies for the Life Sciences","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rosette Nanotubes for Targeted Drug Delivery\",\"authors\":\"S. Suri, H. Fenniri, Baljit Singh\",\"doi\":\"10.1002/9783527610419.NTLS0262\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The sections in this article are \\n \\n \\nIntroduction \\nPeptide-Based Nanotubes \\nSelf-Assembling Rosette Nanotubes \\nSelf-Assembly Peptides \\nG∧C Motif Self-Assembly: Novel Helical Rosette Nanotubes \\nNovelty \\nG∧C Motif Self-Assembly Process \\nBuilt-In Strategy for Manipulating the Properties of RNTs \\n \\n \\nBiological Functions of RNTs \\n \\n \\nStability Issues \\nNanomaterials for Receptor-Mediated Targeting \\nHuman Epidermal Growth Factor Receptor (EGFR) \\nVasoactive Pituitary Adenylate Cyclase (VPAC)-Activating Peptide Receptors \\nTransferrin Receptor (TfR) \\nFolate Receptor (FR) \\n \\n \\nEthical Issues and Future Directions \\nConclusions \\n \\n \\nKeywords: \\n \\nbiofriendly nanotubes; \\ndrug delivery; \\ncancer; \\ninflammation; \\nnanotechnology\",\"PeriodicalId\":312946,\"journal\":{\"name\":\"Nanotechnologies for the Life Sciences\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanotechnologies for the Life Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/9783527610419.NTLS0262\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanotechnologies for the Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9783527610419.NTLS0262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文主要包括:引言:基于肽基的纳米管自组装;玫瑰花状纳米管自组装肽G∧C基序自组装;新型螺旋型纳米管新型G∧C基序自组装工艺内建调控RNTs特性策略RNTs生物学功能稳定性问题受体介导靶向人表皮生长因子受体(EGFR)血管活性垂体腺苷酸环化酶(VPAC)激活肽受体转铁蛋白受体(TfR)叶酸受体(FR)伦理问题及未来发展方向结论关键词:生物相容性纳米管;药物输送;癌症;炎症;纳米技术

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Rosette Nanotubes for Targeted Drug Delivery

The sections in this article are Introduction Peptide-Based Nanotubes Self-Assembling Rosette Nanotubes Self-Assembly Peptides G∧C Motif Self-Assembly: Novel Helical Rosette Nanotubes Novelty G∧C Motif Self-Assembly Process Built-In Strategy for Manipulating the Properties of RNTs Biological Functions of RNTs Stability Issues Nanomaterials for Receptor-Mediated Targeting Human Epidermal Growth Factor Receptor (EGFR) Vasoactive Pituitary Adenylate Cyclase (VPAC)-Activating Peptide Receptors Transferrin Receptor (TfR) Folate Receptor (FR) Ethical Issues and Future Directions Conclusions Keywords: biofriendly nanotubes; drug delivery; cancer; inflammation; nanotechnology

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nanotechnologies for the Life Sciences

自引率

0.00%

发文量